Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bush Budget Request Would Cut 10 Staff Positions At FDA Device Center

This article was originally published in The Gray Sheet

Executive Summary

President Bush's Feb. 4 budget request asks for about $7 million in additional funds for FDA's device program in fiscal year 2009 compared to current levels, but would cut 10 full-time staff equivalents at CDRH

You may also be interested in...



FY 2009 FDA Appropriations Will Likely Have To Wait For Next Administration

House Democratic leaders are signaling an intention to put off finalizing fiscal year 2009 appropriations at least until next March, charging Republican members of Congress and the Bush administration with standing in the way of negotiating mutually agreeable bills

FY 2009 FDA Appropriations Will Likely Have To Wait For Next Administration

House Democratic leaders are signaling an intention to put off finalizing fiscal year 2009 appropriations at least until next March, charging Republican members of Congress and the Bush administration with standing in the way of negotiating mutually agreeable bills

A Matter Of $275 Million: Congress And White House Tussle Over FDA Funds

The Bush Administration tried to get ahead of Congress' relentless criticism that it is under-funding FDA last week by adding $275 million for the agency to its fiscal year 2009 budget request. Critics on Capitol Hill were not impressed

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025746

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel